Study: Inexpensive method detects ALK rearrangement in lung cancer patients
A relatively simple and inexpensive method may be used to determine whether a lung cancer patient is a candidate for crizotinib therapy, according to research published in the August issue of the Journal of Thoracic Oncology, ...
Aug 2, 2011
0
0